TIROMU raised tens of millions of RMB in Pre-A funding to advance clinical trials and registration filing for its fundus injection surgical robot, while continuing R&D on next-generation ophthalmic microsurgery systems.

Edge Medical listed in Hong Kong at a HKD 23.2 billion market cap, signaling its entry into global benchmarking for surgical robotics.

Surgerii Robotics has restarted its A-share IPO process, marking a new phase of maturity for China’s single-port surgical robotics industry.

HUANOVA Biotechnology has raised tens of millions of RMB (approx. US$5–10 million) in Series A+ funding to advance its self-healing supramolecular biomaterial platform and accelerate clinical and global expansion.

Beijing-based medtech company New Cloud Medical announced the completion of its B+ financing round led by Dalton Venture, with participation from Taizhou Angel Fund and Qianfeng Investment. The funds will support clinical trials, regulatory approvals, and international expansion.

Medical device leader Mindray is pursuing a $1 billion Hong Kong IPO to accelerate its global expansion. With 45% of revenue from international markets, the company is transitioning from equipment exports to integrated healthcare solutions, supported by AI and localized manufacturing.

China’s surgical robotics sector hits a turning point as Edge Medical Robotics reports RMB 301M gross profit and near profitability, signaling a shift from R&D-driven growth to sustainable commercialization.

Wiseking Medical has completed a B+ financing round to accelerate commercialization of its NMPA-approved laparoscopic surgical robot and advance next-generation system development.

Cornerstone Robotics raised USD 200 million led by Hong Kong Investment Corporation to accelerate global expansion and next-generation surgical robot development.

Shanghai-based Angtai Weijing Medical Technology has raised hundreds of millions of RMB in Series B funding to advance its microsurgical robotics portfolio: ophthalmic, universal microsurgery, and endo-gastrointestinal systems.

China’s magAssist is among 53 nominees for the prestigious 2025 Prix Galien USA “Best Startup” award, highlighting its innovative cardiopulmonary support devices and growing global recognition.

Robotrak secures Series C funding to advance its high-precision ophthalmic imaging and laser systems, accelerating global commercialization of its Mona IV and Aglaia 577 platforms.